Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.42 |
| ▸ | GMPS | P49915 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA4 | P22748 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 5/20 | 0.36 |
| ▸ | MAOA | P21397 | 4/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13989171 | 0.83 | KMT2A (0.51) | GSTP1GMPSCA12CA4CA9 | |
| SCHEMBL20704575 | 0.83 | GMPS (0.54) | GSTP1GMPSCYP19A1MAOBMAOA | |
| SCHEMBL9718528 | 0.81 | CA12 (0.50) | GSTP1GMPSCA12CA4CA9 | |
| SCHEMBL3204571 | 0.79 | GSTP1 (0.52) | GSTP1CA12CA4CA9CA1 | |
| SCHEMBL7037960 | 0.79 | KMT2A (0.47) | GSTP1GMPSCA12CA4CA9 | |
| SCHEMBL4279603 | 0.79 | MAOA (0.48) | GSTP1GMPSCA12CA9CA1 | |
| SCHEMBL12377614 | 0.77 | HTT (0.36) | GSTP1GMPSCA12CA9MAOB | |
| SCHEMBL2285882 | 0.77 | NPC1 (0.35) | GSTP1GMPSCA12CA9CA1 | |
| SCHEMBL16561463 | 0.77 | KDM4E (0.40) | GSTP1GMPSCA12CA4CA9 | |
| SCHEMBL26673955 | 0.77 | CYP19A1 (0.56) | GSTP1CA12CA4CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2452936-A1 | Compositions and methods for coupling a plurality of compounds to a scaffold | The Scripps Research Institute (US) | 2012-05-16 | — | — | EP | disclosed |
| EP-1910497-A4 | COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD | SCRIPPS RESEARCH INST (US) | 2009-08-12 | — | — | EP | disclosed |
| US-20090181402-A1 | COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-07-16 | — | — | US | disclosed |
| EP-1910497-A2 | COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD | The Scripps Research Institute (US) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007011696-A2 | COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-01-25 | — | — | WO | disclosed |
| US-20070020620-A1 | Compositions and methods for coupling a plurality of compounds to a scaffold | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181402-A1 | COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD | ILK, SEPTIN7, TNKS | GSTP1 3754/4885GMPS 480/4885CA12 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.